- Home
- FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM) w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM) w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid
FluxMPS™ Dulbecco's Modified Eagle Medium (DMEM) w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid
Microfluidics Suitable, quadruple-stage ultra-filtered (0.1 µm ×2 + 0.04 µm ×2) 1X liquid DMEM engineered for microfluidic channels, organ-on-a-chip (OoC), and microphysiological systems (MPS). Formulated without glucose, sodium pyruvate, or phenol red for user-defined carbon-source and metabolic control, and manufactured under an ISO 13485:2016 quality management system.
- Quadruple-stage filtration to a 0.04 µm final pore size (0.1 µm ×2 + 0.04 µm ×2) for microfluidic-channel-safe purity
- Formulated without glucose, sodium pyruvate, and phenol red for precise, user-defined carbon-source control (Warburg-effect studies, glycolysis inhibition, ¹³C tracing)
- Contains L-Glutamine (584 mg/L) and sodium bicarbonate (3700 mg/L) buffering
- Endotoxin release specification: < 0.05 EU/mL (LAL, USP <85>), tested per manufacturing batch
- Manufactured under an ISO 13485:2016 quality management system; final QC and customization at Diagnocine, Totowa, NJ
- 4× BME amino acid and vitamin concentrations to support extended perfusion in microfluidic/OoC/MPS systems
- Incomplete basal medium — a carbon source, serum, or defined supplement must be added before use
- Custom pH, glucose, HEPES, salts & nutrient formulations available on request — support@diagnocine.com
- GlucoseNot added — removed
- L-Glutamine584 mg/L ([+])
- Sodium PyruvateNot added — removed ([-])
- pH (USP <791>)7.4
- Osmolality (USP <785>)310 - 350 mOsm/kg
- Endotoxin (USP <85>)< 0.05 EU/mL
- Filtration0.1µm ×2 + 0.04µm ×2
- Storage2-8°C, protect from light
- Shelf Life12 months from date of manufacture, unopened
- ShippingCold pack (2–8°C)
Engineered where standard media fails
Conventional 0.22 µm filtered media allows mycoplasma (0.2–0.3 µm), sub-visible particulates, and microaggregates to pass freely — clogging microchannels and corrupting sensitive assays. FluxMPS™ closes that gap with a validated multi-stage filtration train.
Microchannel-safe purity
A 0.04 µm final filter provides an ultra-low particulate baseline, supporting stable flow through narrow microfluidic channels.
Total metabolic control
Formulated without glucose or sodium pyruvate, enabling Warburg-effect studies, glycolysis inhibition, and ¹³C metabolic tracing with a user-defined carbon source.
Ultrapure-grade water
Prepared with Ultrapure Type 1 water (18.2 MΩ·cm) under controlled trace-metal and organic-carbon (TOC) specifications.
Low background for imaging
An ultra-low particulate baseline supports confocal live-cell imaging, fluorescent biosensors, and automated high-content analysis on chip.
Rich, stable nutrient profile
4× BME amino acid and vitamin concentrations with micro-batch precision — supporting long-duration MPS perfusion.
Customization on demand
pH, glucose, HEPES, salts, and nutrients adjusted on request. Contact support@diagnocine.com.
Quadruple-stage filtration system
This formulation is filtered through a validated four-stage sequential train — two dedicated prefilter/final-filter pairs — reaching a final pore size of 0.04 µm.
-
1
0.1 µm Prefiltration I
Removes large particulates, cell debris, and protein aggregates; protects the first 0.04 µm cartridge.
-
2
0.04 µm Final filtration I
First 0.04 µm pass; retains sub-micron particulates and microaggregates that pass a 0.22 µm filter.
-
3
0.1 µm Prefiltration II
A second, dedicated prefilter protecting the second 0.04 µm cartridge.
-
4
0.04 µm Final filtration II — Polish
Ultimate polishing filter; aseptic fill & finish in an ISO Class 5 (Class 100) laminar-flow workstation.
Performance vs. conventional media
By USP <788> Method 1 (light obscuration), FluxMPS™ delivers approximately 5× fewer particles ≥10 µm compared with standard 0.22 µm filtered media.
© Diagnocine® — DCP-DMEM-GPR1X
Optimized for next-generation cell biology platforms
FluxMPS™ DMEM w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid is validated for applications where microchannel cleanliness, signal fidelity, and metabolic precision are critical.
Automated Bioreactors & Robotics
An optional 0.01 µm (10 nm) ultra nano-filtered MPS Grade variant is available for automated bioreactors and robotic liquid-handling systems requiring the highest particulate exclusion.
- Total Particulate Exclusion — 0.01 µm final cut-off
- Valve & Sensor Protection for automated perfusion hardware
- Extended Perfusion Stability for long-duration unattended runs
Inquiry Required: The MPS Grade 0.01 µm variant is available on request — contact support@diagnocine.com.
Micro Physiological System (MPS) & Chip
Ultra-low particulate, mycoplasma-retentive-filtered media for perfusion in organ chips, tissue chips (ToC), and body-on-a-chip (BoC) devices.
Warburg Effect & Metabolic Research
Glucose-free, pyruvate-free formulation for Warburg-effect studies, aerobic glycolysis, and cancer metabolomics with a user-defined carbon source.
iPSC-Derived Models
Ultra-clean, low-endotoxin baseline minimizes non-specific signals in iPSC differentiation and functional organoid readouts. Requires carbon-source supplementation before use.
Endothelial & Primary Cells
Particle-free perfusion media for TEER measurement, endothelial monolayer integrity, and primary cell culture.
Metabolic Flux Analysis
Chemically defined, glucose-free formulation for ¹³C metabolic tracing and NMR metabolomics. Not compatible with Agilent Seahorse XF assays, which require bicarbonate-free, phenol red-free medium.
Microscopy & Optical Sensing
Low particulate baseline supports confocal microscopy, fluorescent biosensors, and automated imaging on chip.
Full technical specification
Every lot of FluxMPS™ DMEM w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid is released against multi-parameter QC specifications.
| Parameter | Specification |
|---|---|
| Formulation | [+] L-Glutamine, Sodium Bicarbonate, Calcium, Magnesium / [-] Glucose, Sodium Pyruvate, Phenol Red |
| Appearance | Clear, colorless solution (phenol red-free) |
| pH USP <791> | 7.4 |
| Osmolality USP <785> | 310 - 350 mOsm/kg H₂O |
| Glucose | Not added — removed |
| L-Glutamine | 584 mg/L ([+]) |
| Sodium Pyruvate | Not added — removed ([-]) |
| Phenol Red | Not added — removed ([-]) |
| Parameter | Specification |
|---|---|
| Endotoxin USP <85> | < 0.05 EU/mL (batch release spec) |
| Sterility USP <71> | No growth after 14 days |
| Mycoplasma | 0.1 µm mycoplasma-retentive filtration (not tested per lot) |
| Water purity | Ultrapure Type 1, 18.2 MΩ·cm |
| Manufacturing | ISO 13485:2016 ISO |
| Fill environment | ISO Class 5 (Class 100) |
| Parameter | Specification |
|---|---|
| Storage | 2-8°C, protect from light |
| Freeze–thaw | Do not freeze |
| Shelf life | 12 months from date of manufacture, unopened |
| Shipping | Cold pack (2–8°C) |
| CO₂ requirement | 10% CO₂ incubator required (derived from 3700 mg/L sodium bicarbonate buffering at pH 7.4) |
| Parameter | Specification |
|---|---|
| Raw material grade | Pharmaceutical/research grade, CoA-traceable |
| Manufacturing QMS | ISO 13485:2016 ISO |
| UNSPSC | 41116155 — Molecular biology and cell culture growth media (UNv260801) |
| Regulatory alignment | 21 CFR Part 820 (QMSR) aligned |
| Production method | Micro-batch; Totowa, NJ, USA |
| Intended use | RUO only |
Full composition (mg/L)
Every ingredient below is present in this 1X liquid formulation at the exact concentration listed. Total: 30 components across 4 composition groups within 3 tabs. All values are per-lot verified and reported on the Certificate of Analysis (CoA).
INORGANIC SALTS
| Component | CAS Number | mg/L |
|---|---|---|
| Calcium chloride dihydrate | 10035-04-8 | 265.000 |
| Ferric nitrate nonahydrate | 7782-61-8 | 0.100 |
| Magnesium sulfate anhydrous | 7487-88-9 | 97.720 |
| Potassium chloride | 7447-40-7 | 400.000 |
| Sodium bicarbonate | 144-55-8 | 3700.000 |
| Sodium chloride | 7647-14-5 | 6400.000 |
| Sodium dihydrogen phosphate anhydrous | 7558-80-7 | 109.000 |
AMINO ACIDS
| Component | CAS Number | mg/L |
|---|---|---|
| Glycine | 56-40-6 | 30.000 |
| L-Arginine hydrochloride | 1119-34-2 | 84.000 |
| L-Cystine dihydrochloride | 30925-07-6 | 62.570 |
| L-Glutamine | 56-85-9 | 584.000 |
| L-Histidine hydrochloride monohydrate | 5934-29-2 | 42.000 |
| L-Isoleucine | 73-32-5 | 105.000 |
| L-Leucine | 61-90-5 | 105.000 |
| L-Lysine hydrochloride | 657-27-2 | 146.000 |
| L-Methionine | 63-68-3 | 30.000 |
| L-Phenylalanine | 63-91-2 | 66.000 |
| L-Serine | 56-45-1 | 42.000 |
| L-Threonine | 72-19-5 | 95.000 |
| L-Tryptophan | 73-22-3 | 16.000 |
| L-Tyrosine Disodium Salt dihydrate | 69847-45-6 | 103.790 |
| L-Valine | 72-18-4 | 94.000 |
| Component | CAS Number | mg/L |
|---|---|---|
| VITAMINS | ||
| Choline chloride | 67-48-1 | 4.000 |
| D-Ca-Pantothenate | 137-08-6 | 4.000 |
| Folic acid | 59-30-3 | 4.000 |
| Nicotinamide | 98-92-0 | 4.000 |
| Pyridoxal hydrochloride | 65-22-5 | 4.000 |
| Riboflavin | 83-88-5 | 0.400 |
| Thiamine hydrochloride | 67-03-8 | 4.000 |
| OTHERS | ||
| i-Inositol | 87-89-8 | 7.200 |
Manufacturing & compliance
Every batch is subjected to multi-parameter lot-release testing before distribution.
ISO 13485:2016 QMS
Manufactured by ISO 13485-certified suppliers. Final packaging, QA and testing at DiagnoCine R&D Center; customization at DiagnoCine Precision, Totowa, NJ, USA.
Ultrapure Type 1 Water
18.2 MΩ·cm water prepared under controlled trace-metal and organic-carbon (TOC) specifications.
ISO Class 5 Fill & Finish
Aseptic fill in an ISO Class 5 (Class 100) laminar-flow workstation with real-time particle monitoring.
Micro-Batch Precision
Small-batch production supports tight lot-to-lot consistency in osmolality, pH, and endotoxin release specifications for reproducible long-duration MPS experiments.
Endotoxin — USP <85> BET
LAL assay; assay sensitivity 0.005 EU/mL. Batch release specification: < 0.05 EU/mL.
Particulate — USP <788> Method 1
A quadruple-stage train (0.1 µm ×2 + 0.04 µm ×2) reaches a 0.04 µm final cut-off, five times finer than the 0.22 µm membranes used for conventional sterile filtration.
Osmolality — USP <785>
Freezing-point depression osmometry. Release range: 310 - 350 mOsm/kg H₂O.
Certificate of Analysis (CoA)
Full CoA per lot. Request at support@diagnocine.com with lot number.
- Endotoxin — LAL assay, USP <85> Bacterial Endotoxins Test; assay sensitivity 0.005 EU/mL; release specification < 0.05 EU/mL
- pH, osmolality, conductivity, appearance and clarity
- Sterility
How DCP-DMEM-GPR1X compares
Key differences in grade, filtration, mycoplasma-retentive filtration, water quality, and QC depth relative to conventional 0.22 µm filtered DMEM.
| Parameter | DCP-DMEM-GPR1X (FluxMPS™) | Standard DMEM (0.22 µm) | Competitor DMEM (0.22 µm) |
|---|---|---|---|
| Grade | Microfluidics Suitable | Not specified | Not specified |
| Formulation definition | [+] L-Glutamine, Sodium Bicarbonate, Calcium, Magnesium / [-] Glucose, Sodium Pyruvate, Phenol Red | Standard | Standard |
| Final filtration pore size | 0.04 µm (40 nm) | 0.22 µm | 0.22 µm |
| Number of filtration stages | 4 (0.1 µm ×2 + 0.04 µm ×2) | 1 | 1 |
| Mycoplasma-retentive filtration | check_circle | cancel | cancel |
| Endotoxin (release specification) | FluxMPS™ — < 0.05 EU/mL | Corning classical liquid media — < 0.25 EU/mL Sigma-Aldrich DMEM complete medium — ≤ 2 EU/mL Gibco classical DMEM — Not specified (recorded per lot) |
|
| USP <788> particulate compliance | check_circle Method 1 tested | cancel | cancel |
| Water quality | Ultrapure Type 1, 18.2 MΩ·cm | Unspecified | Unspecified |
| Manufacturing QMS | ISO 13485:2016 | Varies | Varies |
| Microfluidic channel compatibility | check_circle | cancel | cancel |
| Custom formulation | check_circle On request | cancel | cancel |
Comparison figures from published supplier specifications, accessed 2026-09-02. Suppliers that publish no numeric endotoxin specification are shown as "Not specified".
Frequently asked questions
Common questions about FluxMPS™ DMEM w/o Glucose, Sodium Pyruvate, Phenol Red: 1X Liquid (DCP-DMEM-GPR1X).
Supporting literature
- Huh D, et al. Reconstituting organ-level lung functions on a chip. Science. 2010;328:1662–1668. doi:10.1126/science.1188302
- Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol. 2014;32:760–772. doi:10.1038/nbt.2989
- Vander Heiden MG, et al. Understanding the Warburg effect. Science. 2009;324:1029–1033. doi:10.1126/science.1160809
- Sontheimer-Phelps A, et al. Modelling cancer in microfluidic human organs-on-chips. Nat Rev Cancer. 2019;19:65–81. doi:10.1038/s41568-018-0104-6
- van Duinen V, et al. Microfluidic 3D cell culture. Curr Opin Biotechnol. 2015;35:118–126. doi:10.1016/j.copbio.2015.05.002
- Jang KJ, et al. Reproducing human drug toxicities using a Liver-Chip. Sci Transl Med. 2019;11:eaax5516. doi:10.1126/scitranslmed.aax5516
- Kasendra M, et al. Primary human Small Intestine-on-a-Chip. Sci Rep. 2018;8:2871. doi:10.1038/s41598-018-21201-7
- Skardal A, et al. Multi-tissue organ-on-a-chip platform. Sci Rep. 2017;7:8837. doi:10.1038/s41598-017-08879-x
